Literature DB >> 6295007

Immortalization of human lymphocytes by Epstein-Barr virus.

G Miller.   

Abstract

Epstein-Barr virus (EBV) confers upon normal lymphocytes derived from bone marrow the ability to proliferate indefinitely in a test tube. This process, called immortalization, is crucial to the pathogenesis of EBV infections. Inside the immortalized lymphocyte the EBV genome exists as a complete multicopy circular plasmid which is probably not integrated into the cell chromosome. Most of the viral genetic information is not expressed. However, at least six to eight separate regions of the EBV genome encode viral products which are made in the immortalized cell. The identification of the function of these few genes holds some interesting answers to questions concerning the biochemical mechanisms of control of lymphocyte growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295007      PMCID: PMC2596471     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  15 in total

1.  Epstein-Barr virus DNA is amplified in transformed lymphocytes.

Authors:  B Sugden; M Phelps; J Domoradzki
Journal:  J Virol       Date:  1979-09       Impact factor: 5.103

2.  Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line.

Authors:  T Lindahl; A Adams; G Bjursell; G W Bornkamm; C Kaschka-Dierich; U Jehn
Journal:  J Mol Biol       Date:  1976-04-15       Impact factor: 5.469

3.  Epstein-Barr virus: transformation of lymphocytes separated by size or exposed to bromodeoxyuridine and light.

Authors:  E Henderson; J Robinson; A Frank; G Miller
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

Review 4.  The oncogenicity of Epstein-Barr virus.

Authors:  G Miller
Journal:  J Infect Dis       Date:  1974-08       Impact factor: 5.226

5.  Establishment of cell lines from normal adult human blood leukocytes by exposure to Epstein-Barr virus and neutralization by human sera with Epstein-Barr virus antibody.

Authors:  G Miller; H Lisco; H I Kohn; D Stitt; J F Enders
Journal:  Proc Soc Exp Biol Med       Date:  1971-09

6.  Infection of human B lymphocytes with high multiplicities of Epstein-Barr virus: kinetics of EBNA expression, cellular DNA synthesis, and mitosis.

Authors:  J Robinson; D Smith
Journal:  Virology       Date:  1981-03       Impact factor: 3.616

7.  Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus.

Authors:  J E Robinson; N Brown; W Andiman; K Halliday; U Francke; M F Robert; M Andersson-Anvret; D Horstmann; G Miller
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

8.  Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells.

Authors:  W Henle; V Diehl; G Kohn; H Zur Hausen; G Henle
Journal:  Science       Date:  1967-09-01       Impact factor: 47.728

9.  Transformation and chromosome changes induced by Epstein-Barr virus in normal human leukocyte cultures.

Authors:  P Gerper; J Whang-Peng; J H Monroe
Journal:  Proc Natl Acad Sci U S A       Date:  1969-07       Impact factor: 11.205

Review 10.  Human lymphoblastoid cell lines and Epstein-Barr virus: a review of their interrelationships and their relevance to the etiology of leukoproliferative states in man.

Authors:  G Miller
Journal:  Yale J Biol Med       Date:  1971-06
View more
  11 in total

1.  Beta-adrenergic-stimulated adenylate cyclase activity in normal and EBV-transformed lymphocytes.

Authors:  R P Ebstein; M Steinitz; J Mintzer; I Lipshitz; J Stessman
Journal:  Experientia       Date:  1985-12-15

2.  Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC).

Authors:  Mark A Jenkins; Aung Ko Win; Allyson S Templeton; Maggie S Angelakos; Daniel D Buchanan; Michelle Cotterchio; Jane C Figueiredo; Stephen N Thibodeau; John A Baron; John D Potter; John L Hopper; Graham Casey; Steven Gallinger; Loic Le Marchand; Noralane M Lindor; Polly A Newcomb; Robert W Haile
Journal:  Int J Epidemiol       Date:  2018-04-01       Impact factor: 7.196

3.  The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.

Authors:  Alex S Hartlage; Tom Liu; John T Patton; Sabrina L Garman; Xiaoli Zhang; Habibe Kurt; Gerard Lozanski; Mark E Lustberg; Michael A Caligiuri; Robert A Baiocchi
Journal:  Cancer Immunol Res       Date:  2015-03-03       Impact factor: 11.151

4.  Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion.

Authors:  Lawrence R Shiow; Kenneth Paris; Matthew C Akana; Jason G Cyster; Ricardo U Sorensen; Jennifer M Puck
Journal:  Clin Immunol       Date:  2008-12-20       Impact factor: 3.969

5.  SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.

Authors:  Marie Kroemer; Laurie Spehner; Patricia Mercier-Letondal; Laura Boullerot; Stefano Kim; Marine Jary; Jeanne Galaine; Emilie Picard; Christophe Ferrand; Thierry Nguyen; Fabrice Larosa; Olivier Adotévi; Yann Godet; Christophe Borg
Journal:  Oncoimmunology       Date:  2018-01-17       Impact factor: 8.110

6.  Vy-PER: eliminating false positive detection of virus integration events in next generation sequencing data.

Authors:  Michael Forster; Silke Szymczak; David Ellinghaus; Georg Hemmrich; Malte Rühlemann; Lars Kraemer; Sören Mucha; Lars Wienbrandt; Martin Stanulla; Andre Franke
Journal:  Sci Rep       Date:  2015-07-13       Impact factor: 4.379

Review 7.  New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma.

Authors:  Kathy H Y Shair; Akhil Reddy; Vaughn S Cooper
Journal:  Cancers (Basel)       Date:  2018-03-21       Impact factor: 6.639

Review 8.  What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis?

Authors:  Katherine A Buzzard; Simon A Broadley; Helmut Butzkueven
Journal:  Int J Mol Sci       Date:  2012-10-04       Impact factor: 5.923

9.  Fluorogenic Substrates for Visualizing Acidic Organelle Enzyme Activities.

Authors:  Fiona Karen Harlan; Jason Scott Lusk; Breanna Michelle Mohr; Anthony Peter Guzikowski; Robert Hardy Batchelor; Ying Jiang; John Joseph Naleway
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

10.  CdSe Quantum Dots in Human Models Derived from ALS Patients: Characterization, Nuclear Penetration Studies and Multiplexing.

Authors:  Carlota Tosat-Bitrián; Alicia Avis-Bodas; Gracia Porras; Daniel Borrego-Hernández; Alberto García-Redondo; Angeles Martín-Requero; Valle Palomo
Journal:  Nanomaterials (Basel)       Date:  2021-03-09       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.